OC 14.1 phase 3 prospective, randomized, controlled, open-label, multicenter, crossover study of recombinant ADAMTS13 in patients with congenital thrombotic thrombocytopenic purpura - Scully, M; Windyga, J; Mellgård, B (Res Pract Thromb Haemost, 2023)